HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.

Abstract
We evaluated the efficacy of three primaquine (PQ) regimes to prevent relapses with Plasmodium vivax through an open-label randomized trial in Loreto, Peru. Vivax monoinfections were treated with chloroquine for 3 days and PQ in three different regimes: 0.5 mg/kg per day for 5 days (150 mg total), 0.5 mg/kg per day for 7 days (210 mg total), or 0.25 mg/kg per day for 14 days (210 mg total). Biweekly fever assessments and bimonthly thick smears were taken for 210 days. Recurrences after 35 days were considered relapses. One hundred eighty cases were enrolled in each group; 90% of cases completed follow-up. There were no group-related differences in age, sex, or parasitemia. Relapse rates were similar in the 7- and 14-day regimes (16/156 = 10.3% and 22/162 = 13.6%, P = 0.361) and higher in the 5-day group (48/169 = 28.4%, P < 0.001 and P = 0.001, respectively). The 7-day PQ regimen used in Peru is as efficacious as the recommended 14-day regimen and superior to 5 treatment days.
AuthorsSalomón Durand, Cesar Cabezas, Andres G Lescano, Mariela Galvez, Sonia Gutierrez, Nancy Arrospide, Carlos Alvarez, Meddly L Santolalla, David J Bacon, Paul C F Graf
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 91 Issue 1 Pg. 18-26 (Jul 2014) ISSN: 1476-1645 [Electronic] United States
PMID24752682 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© The American Society of Tropical Medicine and Hygiene.
Chemical References
  • Antimalarials
  • Chloroquine
  • Primaquine
Topics
  • Adolescent
  • Adult
  • Aged
  • Antimalarials (pharmacology)
  • Child
  • Child, Preschool
  • Chloroquine (pharmacology)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Malaria, Vivax (drug therapy, parasitology)
  • Male
  • Middle Aged
  • Peru
  • Plasmodium vivax (physiology)
  • Primaquine (pharmacology)
  • Recurrence
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: